None listed
Conditions
Interventions
Procedure/Surgery : We tried to determine the procedural success rate and adverse events of endobiliary RFA in patients with inoperable hilar cholangiocarcinoma. Prior to the procedure, we collected d
Sponsors
Soon Chun Hyang University Hospital Bucheon
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Patients 19 years of age or older 2) Histopathologically confirmed hilar cholangiocarcinoma 3) Segmental bile duct stricture within 1 cm of the hepatic portal segment 4) Unresectable, the patient is at high risk for surgery, or the patient is unwilling to undergo surgery 5) Predicted survival is greater than or equal to 3 months 6) Performance status: ECOG 0 to 1 or Karnofsky performance >80% 7) Consent to participate in this study and have completed an informed consent form
Exclusion criteria
Exclusion criteria: 1) Malignant hilar biliary stricture caused by a disease other than biliary cancer 2) Patients who are ineligible for cholangiopancreatography (ERCP) 3) Patients with uncontrolled coagulation disorders (PT-INR > 1.5, normal 0.85-1.25 or platelet count < 60,000/mm3, normal 150,000-450,000/mm3) 4) Patients who are unable to discontinue dual anti-platelet agents (e.g., patients with coronary artery disease who have undergone a coronary stenting procedure within 6 months). 5) Patients with surgically altered anatomy of the biliary tract 6) Patients who are pregnant or lactating 7) Patients who do not agree to participate in this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Time to recurrent biliary obstruction | — |
Secondary
| Measure | Time frame |
|---|---|
| Technical success;Clinical success;Adverse event;Overall survival | — |
Countries
Korea, Republic of
Contacts
Public ContactIl Sang Shin
Soon Chun Hyang University Hospital Bucheon
Outcome results
None listed